New drug gives hope to heart failure sufferers

By Rory Callinan
Updated September 30 2014 - 10:08am, first published September 1 2014 - 1:25am
Novartis executives say the company will file for approval of the drug, known by the code name LCZ696, in the US by the end of the year. Photo: Peter Rae
Novartis executives say the company will file for approval of the drug, known by the code name LCZ696, in the US by the end of the year. Photo: Peter Rae

A newly developed drug could significantly improve the treatment of heart failure – a condition that is diagnosed in an estimated 30,000 Australians every year.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Queanbeyan news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.